IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine große Auswahl an monoklonalen IL-2/IL-4/IL-7/IL-9/IL-13/IL-15-Rezeptorkomplex-Antikörpern für die Immunologie und die Zellsignalforschung. IL-2/IL-4/IL-7/IL-9/IL-13/IL-15-Rezeptorkomplex-Antikörper sind mit zahlreichen experimentellen Techniken kompatibel, darunter Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffineinbettungen (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA).IL-2/IL-4/IL-7/IL-9/IL-13/IL-15-Rezeptorkomplexe regulieren Immunreaktionen, indem sie die Vermehrung, Differenzierung und das Überleben von T-Zellen beeinflussen. Die Rezeptorkomplexe sind von grundlegender Bedeutung für die Entwicklung und Funktion verschiedener Immunzellen, einschließlich T-Zellen und B-Zellen. Die Forschung hat gezeigt, dass IL-2/IL-4/IL-7/IL-9/IL-13/IL-15-Rezeptorkomplexe an zahlreichen Krankheiten beteiligt sind, darunter Autoimmunerkrankungen und Krebs. Das Verständnis der durch IL-2/IL-4/IL-7/IL-9/IL-13/IL-15-Rezeptorkomplexe vermittelten Signalwege ist für die Entwicklung zielgerichteter Therapien und die Vertiefung des Wissens über die Dynamik des Immunsystems von entscheidender Bedeutung. Die monoklonalen Antikörper von Santa Cruz Biotechnology ermöglichen es den Forschern, die Mechanismen der Immunregulierung zu erforschen und zu bahnbrechenden Entdeckungen in der Immunologie und der therapeutischen Entwicklung beizutragen.
Siehe auch...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
IL-2R Antikörper (A00073.01) | sc-81042 | rat IgG1 | (m) | FCM | m | neu | ||
IL-2R Antikörper (NYRmIL-2R) | sc-73315 | rat IgG1 | (m) | FCM | m | neu | ||
IL-2R Antikörper (YNRhIL2R) | sc-73314 | mouse IgG2a | (h) | FCM | h | neu | ||
IL-2Rα Antikörper (C-9) | sc-393326 | mouse IgG2b κ | 23-49 (m) | WB, IP, IF, ELISA | m, r, h | 2 | ||
IL-2Rα Antikörper (BC96) | sc-19628 | mouse IgG1 κ | FL (h) | FCM | h | 1 | ||
IL-2Rα Antikörper (C-11) | sc-365511 | mouse IgG2b κ | FL (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
IL-2Rα Antikörper (G-7) | sc-365912 | mouse IgM κ | 23-49 (h) | WB, IP, IF, ELISA | h | neu | ||
IL-2Rα Antikörper (H-6) | sc-374034 | mouse IgG2a κ | FL (h) | WB, IP, IF, ELISA | h | neu | ||
IL-2Rα Antikörper (IL2R.1) | sc-57297 | mouse IgG1 | (h) | IF, IHC(P) | h | 1 | ||
IL-2Rβ Antikörper (C-2) | sc-166427 | mouse IgG2b κ | 502-533 (h) | WB, IP, IF, IHC(P), ELISA | h | neu | ||
IL-2Rβ Antikörper (C-10) | sc-393093 | mouse IgG2b κ | 502-522 (m) | WB, IP, IF, ELISA | m, r, h | 1 | ||
IL-2Rβ Antikörper (C-6) | sc-393362 | mouse IgG1 κ | 496-523 (m) | WB, IP, IF, ELISA | m, r, h | 1 | ||
IL-2Rβ Antikörper (D-12) | sc-376003 | mouse IgG1 κ | 521-551 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
IL-2Rβ Antikörper (G-1) | sc-393092 | mouse IgG2a κ | 499-522 (m) | WB, IP, IF, ELISA | m, r, h | 1 | ||
IL-2Rβ Antikörper (TM-β1) | sc-19583 | rat IgG2b | FL (m) | IP, IF, IHC(P), FCM | m | neu | ||
IL-2Rγ Antikörper (A-10) | sc-271060 | mouse IgG2a κ | 342-369 (h) | WB, IP, IF, IHC(P), ELISA | h | 2 | ||
IL-2Rγ Antikörper (E-7) | sc-365910 | mouse IgG1 κ | 22-49 (h) | WB, IP, IF, ELISA | h | neu | ||
IL-2Rγ Antikörper (G-3) | sc-374179 | mouse IgG1 κ | 70-369 (h) | WB, IP, IF, ELISA | h | neu | ||
IL-4Rα Antikörper (H-4) | sc-28361 | mouse IgG2a κ | 527-825 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 15 | ||
IL-4Rα Antikörper (E-1) | sc-165974 | mouse IgG1 κ | 511-810 (m) | WB, IP, IF, IHC(P), ELISA | m, r, h | 4 | ||
IL-4Rα Antikörper (D-2) | sc-137257 | mouse IgG1 κ | 511-810 (m) | WB, IP, IF, ELISA | m | neu | ||
IL-4Rα Antikörper (G-9) | sc-137256 | mouse IgG1 κ | 511-810 (m) | WB, IP, IF, ELISA | m | neu | ||
IL-7R Antikörper (G-11) | sc-514445 | mouse IgG1 κ | 1-215 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
IL-9R Antikörper (F-3) | sc-515622 | mouse IgG1 κ | 41-270 (h) | WB, IP, IF, ELISA | m, r, h | 2 | ||
IL-9R Antikörper (17J-1) | sc-80119 | rat IgG2a | (m) | WB, FCM, ELISA | m | 1 | ||
IL-13Rα1 Antikörper (D-2) | sc-398831 | mouse IgG1 κ | 128-427 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
IL-13Rα1 Antikörper (GM-1C8) | sc-101381 | mouse IgG1 κ | (h) | FCM, ELISA | h | neu | ||
IL-13Rα1 Antikörper (GM-1E7) | sc-101382 | mouse IgG1 κ | (h) | IF, FCM, ELISA | h | 2 | ||
IL-13Rα2 Antikörper (2K8) | sc-134363 | mouse IgG2a κ | 27-127 (h) | WB, IP, ELISA | m, r, h | 7 | ||
IL-13Rα2 Antikörper (YY-23Z) | sc-74160 | mouse IgG1 | (h) | WB, IP | h | 2 | ||
IL-13Rα2 Antikörper (B-D13) | sc-57267 | mouse IgG1 | (h) | IF, IHC(P), FCM | h | 8 | ||
IL-15Rα Antikörper (G-3) | sc-374023 | mouse IgG2a κ | 21-54 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
IL-15Rα Antikörper (G-7) | sc-271366 | mouse IgG1 κ | 24-130 (h) | WB, IP, IF, ELISA | h | 1 |
IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
IL-2Rα CRISPR/Cas9 KO Plasmid (h) | sc-401262 | h | Gene Knockout | GFP | 0 | ||
IL-2Rα HDR Plasmid (h) | sc-401262-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rα Double Nickase Plasmid (h) | sc-401262-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rα Double Nickase Plasmid (h2) | sc-401262-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rα CRISPR/Cas9 KO Plasmid (m) | sc-421105 | m | Gene Knockout | GFP | 0 | ||
IL-2Rα HDR Plasmid (m) | sc-421105-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rα Double Nickase Plasmid (m) | sc-421105-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-2Rα Double Nickase Plasmid (m2) | sc-421105-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IL-2Rβ CRISPR/Cas9 KO Plasmid (h) | sc-403250 | h | Gene Knockout | GFP | 0 | ||
IL-2Rβ HDR Plasmid (h) | sc-403250-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rβ Double Nickase Plasmid (h) | sc-403250-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rβ Double Nickase Plasmid (h2) | sc-403250-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rβ CRISPR/Cas9 KO Plasmid (m) | sc-421106 | m | Gene Knockout | GFP | 0 | ||
IL-2Rβ HDR Plasmid (m) | sc-421106-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rβ Double Nickase Plasmid (m) | sc-421106-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-2Rβ Double Nickase Plasmid (m2) | sc-421106-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IL-2Rγ CRISPR/Cas9 KO Plasmid (h) | sc-401876 | h | Gene Knockout | GFP | 0 | ||
IL-2Rγ HDR Plasmid (h) | sc-401876-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rγ Double Nickase Plasmid (h) | sc-401876-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rγ Double Nickase Plasmid (h2) | sc-401876-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rγ CRISPR/Cas9 KO Plasmid (m) | sc-421107 | m | Gene Knockout | GFP | 0 | ||
IL-2Rγ HDR Plasmid (m) | sc-421107-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rγ Double Nickase Plasmid (m) | sc-421107-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-2Rγ Double Nickase Plasmid (m2) | sc-421107-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IL-4Rα CRISPR/Cas9 KO Plasmid (h) | sc-418209 | h | Gene Knockout | GFP | 0 | ||
IL-4Rα HDR Plasmid (h) | sc-418209-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-4Rα Double Nickase Plasmid (h) | sc-418209-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-4Rα Double Nickase Plasmid (h2) | sc-418209-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-4Rα CRISPR/Cas9 KO Plasmid (m) | sc-421111 | m | Gene Knockout | GFP | 1 | ||
IL-4Rα HDR Plasmid (m) | sc-421111-HDR | m | Homology Directed Repair | Puromycin | 1 | ||
IL-4Rα Double Nickase Plasmid (m) | sc-421111-NIC | m | Gene Knockout | Puromycin | 1 | ||
IL-4Rα Double Nickase Plasmid (m2) | sc-421111-NIC-2 | m | Gene Knockout | Puromycin | 1 | ||
IL-7R CRISPR/Cas9 KO Plasmid (h) | sc-401536 | h | Gene Knockout | GFP | 0 | ||
IL-7R HDR Plasmid (h) | sc-401536-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-7R Double Nickase Plasmid (h) | sc-401536-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-7R Double Nickase Plasmid (h2) | sc-401536-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-7R CRISPR/Cas9 KO Plasmid (m) | sc-421118 | m | Gene Knockout | GFP | 0 | ||
IL-7R HDR Plasmid (m) | sc-421118-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-7R Double Nickase Plasmid (m) | sc-421118-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-7R Double Nickase Plasmid (m2) | sc-421118-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IL-9R CRISPR/Cas9 KO Plasmid (m) | sc-421120 | m | Gene Knockout | GFP | 0 | ||
IL-9R HDR Plasmid (m) | sc-421120-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-9R Double Nickase Plasmid (m) | sc-421120-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-9R Double Nickase Plasmid (m2) | sc-421120-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IL-15Rα CRISPR/Cas9 KO Plasmid (h) | sc-416909 | h | Gene Knockout | GFP | 0 | ||
IL-15Rα HDR Plasmid (h) | sc-416909-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-15Rα Double Nickase Plasmid (h) | sc-416909-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-15Rα Double Nickase Plasmid (h2) | sc-416909-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-15Rα CRISPR/Cas9 KO Plasmid (m) | sc-421090 | m | Gene Knockout | GFP | 0 | ||
IL-15Rα HDR Plasmid (m) | sc-421090-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-15Rα Double Nickase Plasmid (m) | sc-421090-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-15Rα Double Nickase Plasmid (m2) | sc-421090-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IL-13Rα1 CRISPR/Cas9 KO Plasmid (h) | sc-405042 | h | Gene Knockout | GFP | 0 | ||
IL-13Rα1 HDR Plasmid (h) | sc-405042-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-13Rα1 Double Nickase Plasmid (h) | sc-405042-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-13Rα1 Double Nickase Plasmid (h2) | sc-405042-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-13Rα1 CRISPR/Cas9 KO Plasmid (m) | sc-421087 | m | Gene Knockout | GFP | 0 | ||
IL-13Rα1 HDR Plasmid (m) | sc-421087-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-13Rα1 Double Nickase Plasmid (m) | sc-421087-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-13Rα1 Double Nickase Plasmid (m2) | sc-421087-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IL-13Rα2 CRISPR/Cas9 KO Plasmid (h) | sc-402525 | h | Gene Knockout | GFP | 0 | ||
IL-13Rα2 CRISPR/Cas9 KO Plasmid (h2) | sc-402525-KO-2 | h | Gene Knockout | GFP | 0 | ||
IL-13Rα2 HDR Plasmid (h2) | sc-402525-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
IL-13Rα2 Double Nickase Plasmid (h) | sc-402525-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-13Rα2 Double Nickase Plasmid (h2) | sc-402525-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-13Rα2 CRISPR/Cas9 KO Plasmid (m) | sc-421088 | m | Gene Knockout | GFP | 0 | ||
IL-13Rα2 HDR Plasmid (m) | sc-421088-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-13Rα2 Double Nickase Plasmid (m) | sc-421088-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-13Rα2 Double Nickase Plasmid (m2) | sc-421088-NIC-2 | m | Gene Knockout | Puromycin | 0 |
IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
IL-2Rα CRISPR Activation Plasmid (h) | sc-401262-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
/%base_sku__display_name%/ CRISPR Activation Plasmid (h2) | sc-401262-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rα Lentiviral Activation Particles (h) | sc-401262-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rα Lentiviral Activation Particles (h2) | sc-401262-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rα CRISPR Activation Plasmid (m) | sc-421105-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rα CRISPR Activation Plasmid (m2) | sc-421105-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rα Lentiviral Activation Particles (m) | sc-421105-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rα Lentiviral Activation Particles (m2) | sc-421105-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ CRISPR Activation Plasmid (h) | sc-403250-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ CRISPR Activation Plasmid (h2) | sc-403250-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ Lentiviral Activation Particles (h) | sc-403250-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ Lentiviral Activation Particles (h2) | sc-403250-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ CRISPR Activation Plasmid (m) | sc-421106-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ CRISPR Activation Plasmid (m2) | sc-421106-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ Lentiviral Activation Particles (m) | sc-421106-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ Lentiviral Activation Particles (m2) | sc-421106-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rγ CRISPR Activation Plasmid (h) | sc-401876-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rγ CRISPR Activation Plasmid (h2) | sc-401876-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rγ Lentiviral Activation Particles (h) | sc-401876-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rγ Lentiviral Activation Particles (h2) | sc-401876-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rγ CRISPR Activation Plasmid (m) | sc-421107-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rγ CRISPR Activation Plasmid (m2) | sc-421107-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rγ Lentiviral Activation Particles (m) | sc-421107-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rγ Lentiviral Activation Particles (m2) | sc-421107-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-4Rα CRISPR Activation Plasmid (h) | sc-418209-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-4Rα CRISPR Activation Plasmid (h2) | sc-418209-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-4Rα Lentiviral Activation Particles (h) | sc-418209-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-4Rα Lentiviral Activation Particles (h2) | sc-418209-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-4Rα CRISPR Activation Plasmid (m) | sc-421111-ACT | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
IL-4Rα CRISPR Activation Plasmid (m2) | sc-421111-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
IL-4Rα Lentiviral Activation Particles (m) | sc-421111-LAC | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
IL-4Rα Lentiviral Activation Particles (m2) | sc-421111-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
IL-7R CRISPR Activation Plasmid (h) | sc-401536-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-7R CRISPR Activation Plasmid (h2) | sc-401536-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-7R Lentiviral Activation Particles (h) | sc-401536-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-7R Lentiviral Activation Particles (h2) | sc-401536-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-7R CRISPR Activation Plasmid (m) | sc-421118-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-7R CRISPR Activation Plasmid (m2) | sc-421118-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-7R Lentiviral Activation Particles (m) | sc-421118-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-7R Lentiviral Activation Particles (m2) | sc-421118-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-9R CRISPR Activation Plasmid (m) | sc-421120-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-9R CRISPR Activation Plasmid (m2) | sc-421120-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-9R Lentiviral Activation Particles (m) | sc-421120-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-9R Lentiviral Activation Particles (m2) | sc-421120-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα CRISPR Activation Plasmid (h) | sc-416909-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα CRISPR Activation Plasmid (h2) | sc-416909-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα Lentiviral Activation Particles (h) | sc-416909-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα Lentiviral Activation Particles (h2) | sc-416909-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα CRISPR Activation Plasmid (m) | sc-421090-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα CRISPR Activation Plasmid (m2) | sc-421090-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα Lentiviral Activation Particles (m) | sc-421090-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα Lentiviral Activation Particles (m2) | sc-421090-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα1 CRISPR Activation Plasmid (h) | sc-405042-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα1 CRISPR Activation Plasmid (h2) | sc-405042-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα1 Lentiviral Activation Particles (h) | sc-405042-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα1 Lentiviral Activation Particles (h2) | sc-405042-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα1 CRISPR Activation Plasmid (m) | sc-421087-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα1 CRISPR Activation Plasmid (m2) | sc-421087-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα1 Lentiviral Activation Particles (m) | sc-421087-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα1 Lentiviral Activation Particles (m2) | sc-421087-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 CRISPR Activation Plasmid (h) | sc-402525-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 CRISPR Activation Plasmid (h2) | sc-402525-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 Lentiviral Activation Particles (h) | sc-402525-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 Lentiviral Activation Particles (h2) | sc-402525-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 CRISPR Activation Plasmid (m) | sc-421088-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 CRISPR Activation Plasmid (m2) | sc-421088-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 Lentiviral Activation Particles (m) | sc-421088-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 Lentiviral Activation Particles (m2) | sc-421088-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
IL-2Rα siRNA (h) | sc-29367 | h | Gene Silencing | N/A | 0 | ||
IL-2Rα shRNA Plasmid (h) | sc-29367-SH | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rα shRNA (h) Lentivirale Partikel | sc-29367-V | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rα siRNA (m) | sc-35657 | m | Gene Silencing | N/A | 0 | ||
IL-2Rα shRNA Plasmid (m) | sc-35657-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rα shRNA (m) Lentivirale Partikel | sc-35657-V | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rβ siRNA (h) | sc-35654 | h | Gene Silencing | N/A | 0 | ||
IL-2Rβ shRNA Plasmid (h) | sc-35654-SH | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rβ shRNA (h) Lentivirale Partikel | sc-35654-V | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rβ siRNA (m) | sc-35655 | m | Gene Silencing | N/A | 0 | ||
IL-2Rβ shRNA Plasmid (m) | sc-35655-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rβ shRNA (m) Lentivirale Partikel | sc-35655-V | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rγ siRNA (h) | sc-35653 | h | Gene Silencing | N/A | 0 | ||
IL-2Rγ shRNA Plasmid (h) | sc-35653-SH | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rγ shRNA (h) Lentivirale Partikel | sc-35653-V | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rγ siRNA (m) | sc-35656 | m | Gene Silencing | N/A | 0 | ||
IL-2Rγ shRNA Plasmid (m) | sc-35656-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rγ shRNA (m) Lentivirale Partikel | sc-35656-V | m | Gene Silencing | Puromycin | 0 | ||
IL-4Rα siRNA (h) | sc-35661 | h | Gene Silencing | N/A | 1 | ||
IL-4Rα shRNA Plasmid (h) | sc-35661-SH | h | Gene Silencing | Puromycin | 1 | ||
IL-4Rα shRNA (h) Lentivirale Partikel | sc-35661-V | h | Gene Silencing | Puromycin | 1 | ||
IL-4Rα siRNA (m) | sc-35662 | m | Gene Silencing | N/A | 3 | ||
IL-4Rα shRNA Plasmid (m) | sc-35662-SH | m | Gene Silencing | Puromycin | 3 | ||
IL-4Rα shRNA (m) Lentivirale Partikel | sc-35662-V | m | Gene Silencing | Puromycin | 3 | ||
IL-7R siRNA (h) | sc-35664 | h | Gene Silencing | N/A | 4 | ||
IL-7R shRNA Plasmid (h) | sc-35664-SH | h | Gene Silencing | Puromycin | 4 | ||
IL-7R shRNA (h) Lentivirale Partikel | sc-35664-V | h | Gene Silencing | Puromycin | 4 | ||
IL-7R siRNA (m) | sc-35665 | m | Gene Silencing | N/A | 0 | ||
IL-7R shRNA Plasmid (m) | sc-35665-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-7R shRNA (m) Lentivirale Partikel | sc-35665-V | m | Gene Silencing | Puromycin | 0 | ||
IL-9R siRNA (h) | sc-40049 | h | Gene Silencing | N/A | 0 | ||
IL-9R shRNA Plasmid (h) | sc-40049-SH | h | Gene Silencing | Puromycin | 0 | ||
IL-9R shRNA (h) Lentivirale Partikel | sc-40049-V | h | Gene Silencing | Puromycin | 0 | ||
IL-9R siRNA (m) | sc-40050 | m | Gene Silencing | N/A | 0 | ||
IL-9R shRNA Plasmid (m) | sc-40050-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-9R shRNA (m) Lentivirale Partikel | sc-40050-V | m | Gene Silencing | Puromycin | 0 | ||
IL-15Rα siRNA (h) | sc-40051 | h | Gene Silencing | N/A | 1 | ||
IL-15Rα shRNA Plasmid (h) | sc-40051-SH | h | Gene Silencing | Puromycin | 1 | ||
IL-15Rα shRNA (h) Lentivirale Partikel | sc-40051-V | h | Gene Silencing | Puromycin | 1 | ||
IL-15Rα siRNA (m) | sc-40052 | m | Gene Silencing | N/A | 1 | ||
IL-15Rα shRNA Plasmid (m) | sc-40052-SH | m | Gene Silencing | Puromycin | 1 | ||
IL-15Rα shRNA (m) Lentivirale Partikel | sc-40052-V | m | Gene Silencing | Puromycin | 1 | ||
IL-13Rα1 siRNA (h) | sc-63337 | h | Gene Silencing | N/A | 1 | ||
IL-13Rα1 shRNA Plasmid (h) | sc-63337-SH | h | Gene Silencing | Puromycin | 1 | ||
IL-13Rα1 shRNA (h) Lentivirale Partikel | sc-63337-V | h | Gene Silencing | Puromycin | 1 | ||
IL-13Rα1 siRNA (m) | sc-63338 | m | Gene Silencing | N/A | 0 | ||
IL-13Rα1 shRNA Plasmid (m) | sc-63338-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-13Rα1 shRNA (m) Lentivirale Partikel | sc-63338-V | m | Gene Silencing | Puromycin | 0 | ||
IL-13Rα2 siRNA (h) | sc-63339 | h | Gene Silencing | N/A | 2 | ||
IL-13Rα2 shRNA Plasmid (h) | sc-63339-SH | h | Gene Silencing | Puromycin | 2 | ||
IL-13Rα2 shRNA (h) Lentivirale Partikel | sc-63339-V | h | Gene Silencing | Puromycin | 2 | ||
IL-13Rα2 siRNA (m) | sc-63340 | m | Gene Silencing | N/A | 0 | ||
IL-13Rα2 shRNA Plasmid (m) | sc-63340-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-13Rα2 shRNA (m) Lentivirale Partikel | sc-63340-V | m | Gene Silencing | Puromycin | 0 |